Prefusion- stabilization of the Herpesvirus fusion protein enhances vaccine potency
McCallum, M., Veesler, D.To be published.
Experimental Data Snapshot
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| SARS-CoV-2 S 2P with C-terminal 4X oP3h motif (RINAIET) | 1,208 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  | ![]() | |
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Glycosylation | |||||
| Glycosylation Sites: 14 | |||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| NAG Download:Ideal Coordinates CCD File | AA [auth B] BA [auth B] CA [auth B] D [auth A] DA [auth B] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
| Task | Software Package | Version |
|---|---|---|
| RECONSTRUCTION | cryoSPARC |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | -- |